In a statement posted on UFC.com earlier this afternoon, the promotion has announced that Brock Lesnar failed a second anti-doping test in conjunction with UFC 200, which happened on July 9. This time, the sample was taken “in-competition” on July 9, the same day of the event where Lesnar defeated Mark Hunt in a heavyweight bout.
The statement reads as follows:
“The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Brock Lesnar that his in-competition sample collection from July 9, 2016, at UFC 200, has tested positive for the same substance as his previously announced out-of-competition collection on June 28, 2016.“
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed. The Nevada State Athletic Commission also retains jurisdiction over this matter as the sample collection was performed at UFC 200 in Las Vegas.
“Consistent with all previous potential anti-doping violations, additional information will be provided at the appropriate time as the process moves forward.”
Bill Says: As if this couldn’t get worse for the MMA future of Brock Lesnar at this point. To this point, Lesnar had never failed a drug test, so these two tests in a row are certainly interesting. For what it’s worth, WWE is still advertising Lesnar vs. Orton, and there are reports circulating that even if Lesnar faces discipline from USADA/NSAC, he can work SummerSlam as New York does not license individual wrestlers but instead licenses promoters. More to follow, for sure.